We specialize in the development and commercialization of controlled substances (CI-CV) including drug products used for pain management and ADHD. We have particular expertise in abuse deterrent technologies and complex IR/ER products. Our array of services includes contract dosage form development, commercial manufacturing, packaging and analytical services.
Our customers span from many of today’s largest pharmaceutical companies to single molecule biotech companies and encompass both generic and branded products. We leverage our expertise and strong compliance focus to bring our customers’ products through the development, regulatory, and manufacturing process in the most efficient and cost effective manner possible so that we can meet our customers launch and sales goals.
Halo Pharma’s capabilities in the areas of tech transfer, process and product development, production, scale-up and validation, and analytical method development allow us to partner with clients from development through commercialization or at any point along the way.
While we excel at all of our scientific and manufacturing know-how, we strive to be the best partner. We are collaborative and responsive, working with customers to find effective and scalable solutions to their pharmaceutical development and manufacturing challenges. With our vast knowledge of drug product development and manufacturing, having commercialized of 100 products in the last 10 years, we possess a wealth of know how that can be complementary to our customer’s in house expertise. We are also always exploring new ideas and approaches. We pride ourselves on being flexible, and unlike many larger CDMO’s, we and can easily accommodate changes that may arise during a customer’s project at any point in a product’s life cycle.
Most importantly we value our customers. We strive every day to be a good partner and deliver on our commitments.